Stock Events

Stock Events

Fate Therapeutics (F6T.F) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.48

-0.46

-0.44

-0.41

Details

Expected EPS

-0.4374325616

Actual EPS

-0.435784

Surprise EPS

0

Surprise Percent

+0.38%

Description

Fate Therapeutics (F6T.F) has reported earnings of -0.435784 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.